Bayer Cropscience India Limited (BAYERCROP) AI Stock Analysis

Bayer Cropscience India Limited

(NSE:BAYERCROP)

Select Model

Rating:68Neutral

Price Target:INR 3,557.00▲(9.01% Upside)

Action:reiterated

Date:08/28/26

The score is driven primarily by strong financial quality—especially the very low-debt balance sheet and solid profitability—tempered by margin/cash-flow volatility. Technical indicators are weak with the stock trading below key moving averages and negative MACD, while valuation is supported by a strong dividend yield but constrained by a ~25 P/E.

Positive Factors

Very low leverageThe exceptionally low debt burden gives Bayer CropScience India substantial financial resilience and flexibility. A steadily expanding equity base provides an additional buffer, supporting investment in products, distribution, and agronomic capabilities without significant balance-sheet strain.

Negative Factors

Margin compressionThe decline from earlier margin levels indicates that profitability has not been consistently sustained at its strongest historical rate. Persistent pressure on operating profitability could reduce the funds available for innovation, distribution support, and future growth initiatives.

Bayer Cropscience India Limited (BAYERCROP) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 153.51B
Dividend Yield: 4.60%
Average Volume (3M): 1,632
Price to Earnings (P/E): 20.0
Beta (1Y): 0.96
Revenue Growth: -2.78%
EPS Growth: 23.56%
Country: India
Employees: 1,317
Sector: General
Sector Strength: 55
Industry: Agricultural Inputs

Bayer Cropscience India Limited Business Overview & Revenue Model

Company Description

Bayer CropScience Limited, founded in Thane, India, in 1958, is a diversified enterprise involved in various sectors, including agriculture, pharmaceuticals, and consumer health, with a global reach encompassing India, Germany, and Bangladesh, among...

Bayer Cropscience India Limited Financial Statement Overview

Summary

Strong overall fundamentals supported by revenue growth and solid profitability (FY2026 net margin ~12%) alongside an exceptionally low-leverage balance sheet. The main constraints are margin compression versus FY2023–FY2024 and historically volatile operating/free cash flow despite a FY2026 rebound.

Income Statement

78Positive

Balance Sheet

90Very Positive

Cash Flow

68Positive

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	55.95B	56.75B	54.73B	51.06B	51.40B	47.34B
Gross Profit	22.08B	17.65B	20.59B	21.81B	23.09B	20.57B
EBITDA	10.58B	9.69B	6.92B	9.79B	9.27B	8.15B
Net Income	7.32B	6.89B	5.68B	7.41B	7.58B	6.45B
Balance Sheet
Total Assets	0	56.99B	52.46B	45.97B	46.79B	43.53B
Cash, Cash Equivalents and Short-Term Investments	14.72B	14.79B	9.29B	12.11B	9.02B	8.19B
Total Debt	0	818.00M	1.05B	471.00M	735.00M	864.00M
Total Liabilities	-29.66B	27.34B	23.95B	17.48B	19.66B	18.29B
Stockholders Equity	29.66B	29.66B	28.50B	28.49B	27.12B	25.24B
Cash Flow
Free Cash Flow	-682.00M	10.57B	2.59B	9.06B	5.32B	1.60B
Operating Cash Flow	-349.00M	10.97B	3.00B	9.52B	6.09B	2.15B
Investing Cash Flow	-90.00M	414.00M	389.00M	4.00M	833.00M	642.00M
Financing Cash Flow	-1.84B	-6.12B	-6.10B	-6.56B	-6.13B	-7.03B

Bayer Cropscience India Limited Technical Analysis

Technical Analysis SentimentNegative

Last Price3263.00

Price Trends

50DMA3733.83Negative

100DMA3941.06Negative

200DMA4225.21Negative

Market Momentum

MACD-127.92Positive

RSI27.00Positive

STOCH7.81Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BAYERCROP, the sentiment is Negative. The current price of 3263.00 is below the 20-day moving average (MA) of 3457.09, below the 50-day MA of 3733.83, and below the 200-day MA of 4225.21, indicating a bearish trend. The MACD of -127.92 indicates Positive momentum. The RSI at 27.00 is Positive, neither overbought nor oversold. The STOCH value of 7.81 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BAYERCROP.

Bayer Cropscience India Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:BAYERCROP against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:SHARDACROP	76Outperform	INR 59.96B	9.58	―	2.26%	18.52%	49.11%
IN:DHANUKA	73Outperform	INR 43.75B	16.48	―	0.20%	-5.63%	-11.38%
IN:BAYERCROP	68Neutral	INR 146.65B	19.99	―	4.60%	-2.78%	23.56%
IN:PIIND	66Neutral	INR 316.94B	27.34	―	0.48%	-16.57%	-27.71%
IN:RALLIS	63Neutral	INR 35.75B	18.14	―	1.63%	6.82%	11.93%
IN:UPL	58Neutral	INR 434.20B	21.45	―	1.17%	12.86%	72.26%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%

* General Sector Average

Performance Comparison

IN:BAYERCROP and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:BAYERCROP	Bayer Cropscience India Limited	3263.00	-1444.97	-30.69%
IN:DHANUKA	Dhanuka Agritech Limited	981.50	-322.04	-24.70%
IN:PIIND	PI Industries Limited	2089.00	-1580.52	-43.07%
IN:RALLIS	Rallis India Limited	183.85	-75.13	-29.01%
IN:SHARDACROP	Sharda Cropchem Ltd.	664.60	-135.86	-16.97%
IN:UPL	UPL Limited	514.35	-208.80	-28.87%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 28, 2026

Bayer Cropscience India Limited AI Stock Analysis